NDC 0121-1298 Cimetidine
Cimetidine Hydrochloride Solution Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0121 - Pharmaceutical Associates, Inc.
- 0121-1298 - Cimetidine
Product Packages
NDC Code 0121-1298-40
Package Description: 4 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 6.67 mL in 1 CUP, UNIT-DOSE (0121-1298-93)
Product Details
What is NDC 0121-1298?
What are the uses for Cimetidine?
What are Cimetidine Active Ingredients?
- CIMETIDINE HYDROCHLORIDE 400 mg/6.67mL - A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
What is the NDC to RxNorm Crosswalk for Cimetidine?
- RxCUI: 212787 - cimetidine HCl 300 MG in 5 mL Oral Solution
- RxCUI: 212787 - cimetidine 60 MG/ML Oral Solution
- RxCUI: 212787 - cimetidine 300 MG per 5 ML Oral Solution
- RxCUI: 212787 - cimetidine 400 MG per 6.7 ML Oral Solution
Which are the Pharmacologic Classes for Cimetidine?
* Please review the disclaimer below.
Patient Education
Cimetidine
Cimetidine is used to treat ulcers; gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and injury of the food pipe (esophagus); and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome. Over-the-counter cimetidine is used to prevent and treat symptoms of heartburn associated with acid indigestion and sour stomach. Cimetidine is in a class of medications called H2 blockers. It decreases the amount of acid made in the stomach.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".